VALIDATE is an international network of researchers developing vaccines against globally significant diseases caused by complex intracellular pathogens. Our initial focus is on tuberculosis (TB), leishmaniasis, melioidosis, and leprosy, which cause substantial mortality and morbidity across the globe, particularly in low and middle-income countries (LMICs). By working together, we will advance research more quickly and effectively.
VALIDATE’s vision is to accelerate vaccine R&D for TB, leishmaniasis, melioidosis and leprosy by creating an engaged and interactive community of researchers who form new cross-pathogen, cross-continent, cross-species and cross-discipline collaborations, generating new ideas, taking advantage of synergies and quickly disseminating lessons learned across the Network. We provide pump-priming grants for ground-breaking projects by members.
We also aim to facilitate continuing professional development (CPD) and career progression among our members, particularly Early Career and LMIC Researchers, by providing training grants, workshops, a mentoring scheme and seminars, as well as this central hub website highlighting job and training opportunities worldwide.
Becoming a member is free and easy – for details on how to join, click here.
Find out more:
The benefits of being a VALIDATE member
Our current members